Turning back to cancer-related trends, sometimes its the smallest of advances that has the biggest impact. Take for example the topic of liquid biopsies. ¬†You’ve got to see the trajectory on this science/medical topic.

The topic is trending, but still pulling low media rating numbers. Liquid biopsies is up + 3 points or 8 percent at a moderate 39 rating in the Science Sector. 4-year media momentum has been consistently positive with a few exceptions early 2014. The topic was triggered in the media in July 2012 with just the hint of possible media interest.

Turning back to cancer-related trends, sometimes its the smallest of advances that has the biggest impact. Take for example the topic of liquid biopsies.

The topic is trending, but still pulling low media rating numbers. Liquid biopsies is up + 3 points or 8 percent at a moderate 39 rating in the Science Sector. 4-year media momentum has been consistently positive with a few exceptions in early 2014. The topic hit a critical media momentum trigger in July 2012 that ignited an amazing media run.

Cumulative 4-year media growth is the key metric here. At +31 percent, liquid biopsies has been trending under the mainstream media radar for nearly 4-years straight.

For a little background liquid biopsies are a new type of blood test that is starting to transform cancer treatment, sparing some patients the surgical and needle biopsies long needed to guide their care.

The tests, called liquid biopsies, capture cancer cells or DNA that tumors shed into the blood, instead of taking tissue from the tumor itself. A lot is still unknown about the value of these tests, but many doctors think they are a big advance that could make personalized medicine possible for far more people.

We’ll be watching this topic as it continues its amazing media trajectory along with 90+ trending topics in the Science Sector. Checkout the Conditions and Disease Sector to see how many of the underlying issues addressed by these new advances are getting the critical media attention they deserve.